New method developed for triggering and imaging seizures in epilepsy patients

Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery.

BioCryst Pharmaceuticals Inc Patent Filing for Complement System Inhibitors

Share this article According to GlobalData’s company profile on BioCryst Pharmaceuticals, Cancer treatment biomarkers was a key innovation area identified from patents. BioCryst Pharmaceuticals‘s grant

April 24, 2024

ONL Therapeutics seeks upto $100m to further eye disease pipeline – Pharmaceutical Technology

Adult woman having a visit at female opthalmologist’s office. Credit: macniak via Getty Images Ophthalmological disease company ONL Therapeutics is currently seeking investor capital or

November 1, 2023

Drugs are approved — and made available — faster in US than most of EU, data show

New drugs in the US were, on average, approved months before winning approval in the EU, according to new data from The IQVIA Institute for

December 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.